Reference
Ibrutinib (IMBRUVICA): Package Insert Updates to Dose Modifications for Adverse Reactions and to Special Warnings and Precautions for Use Internet Document : 30 Nov 2023. Available from: URL: https://npra.gov.my/index.php/en/component/content/article/449-english/safety-alerts-main/safety-alerts-2023/1527546-ibrutinib-imbruvica-package-insert-updates-to-dose-modifications-for-adverse-reactions-and-to-special-warnings-and-precautions-for-use.html?Itemid=1391
Rights and permissions
About this article
Cite this article
Labelling of ibrutinib updated with dose modifications in Malaysia. Reactions Weekly 1987, 5 (2023). https://doi.org/10.1007/s40278-023-51749-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-51749-x